课题基金 / 基金详情

NANDROLONE IN HIV ASSOCIATED WEIGHT LOSS

NANDROLONE IN HIV ASSOCIATED WEIGHT LOSS
诺龙在艾滋病毒相关减肥中的作用
批准号:
6115455
负责人:
Kathleen Mulligan
金额:
$3.1万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

Kathleen Mulligan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a randomized, double-blind, placebo-controlled study in patients with HIV-associated weight loss. Eligible individuals will receive nandrolone decanoate or placebo by weekly intramuscular injection for 12 weeks. All patients who successfully complete a 12-week placebo- controlled phase will be eligible to receive open-label nandrolone for an additional 12 weeks. Response to treatment will be evaluated by measuring body weight and composition, functional performance, quality of life, and energy and macronutrient intake. Safety, HIV disease progression, and immunologic status will be closely monitored throughout the study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
  • 批准号:
    9069958
  • 项目类别:
  • 资助金额:
    $61.32万
  • 财政年份:
    2013
  • 负责人:
    Kathleen Mulligan
  • 依托单位:
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
  • 批准号:
    8438137
  • 项目类别:
  • 资助金额:
    $62.36万
  • 财政年份:
    2013
  • 负责人:
    Kathleen Mulligan
  • 依托单位:
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
  • 批准号:
    9294153
  • 项目类别:
  • 资助金额:
    $61.68万
  • 财政年份:
    2013
  • 负责人:
    Kathleen Mulligan
  • 依托单位:
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
  • 批准号:
    8666804
  • 项目类别:
  • 资助金额:
    $60.44万
  • 财政年份:
    2013
  • 负责人:
    Kathleen Mulligan
  • 依托单位:
海外基金